Drug
12%azelaic Acid
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Taste Disorder | 83 | 110.2 | 123.1 | signal |
| 2 | Folliculitis | 36 | 92.7 | 97.1 | signal |
| 3 | Wound Infection | 31 | 75.8 | 78.9 | signal |
| 4 | Epilepsy | 85 | 74.0 | 82.8 | signal |
| 5 | Back Injury | 27 | 66.3 | 68.6 | signal |
| 6 | Bursitis | 30 | 66.1 | 68.6 | signal |
| 7 | Synovitis | 44 | 64.8 | 68.5 | signal |
| 8 | Pemphigus | 30 | 64.1 | 66.6 | signal |
| 9 | Hypercholesterolaemia | 22 | 61.1 | 62.8 | signal |
| 10 | Red Blood Cell Sedimentation Rate Increased | 25 | 59.9 | 61.8 | signal |
| 11 | Helicobacter Infection | 21 | 54.7 | 56.2 | signal |
| 12 | Pericarditis | 34 | 54.2 | 56.6 | signal |
| 13 | Joint Range Of Motion Decreased | 22 | 43.7 | 44.9 | signal |
| 14 | Sleep Disorder Due To A General Medical Condition | 26 | 42.7 | 44.1 | signal |
| 15 | Hand Deformity | 21 | 42.6 | 43.7 | signal |
| 16 | Laryngitis | 16 | 39.1 | 39.9 | signal |
| 17 | Poor Quality Product Administered | 14 | 36.4 | 37.0 | signal |
| 18 | Wound | 36 | 34.4 | 36.0 | signal |
| 19 | Fibromyalgia | 31 | 33.9 | 35.2 | signal |
| 20 | Contraindicated Product Administered | 36 | 31.7 | 33.1 | signal |
| 21 | Gastrooesophageal Reflux Disease | 93 | 30.8 | 34.7 | signal |
| 22 | Irritable Bowel Syndrome | 24 | 29.8 | 30.7 | signal |
| 23 | Glossodynia | 25 | 29.7 | 30.6 | signal |
| 24 | Obesity | 17 | 28.3 | 28.9 | signal |
| 25 | Night Sweats | 34 | 28.0 | 29.2 | signal |
| 26 | Autoimmune Disorder | 10 | 27.7 | 28.1 | signal |
| 27 | Migraine | 90 | 25.2 | 28.3 | signal |
| 28 | Drug Intolerance | 87 | 24.0 | 26.8 | signal |
| 29 | Prescribed Overdose | 17 | 23.3 | 23.8 | signal |
| 30 | Hepatic Cirrhosis | 16 | 22.7 | 23.2 | signal |
| 31 | C-reactive Protein Increased | 31 | 22.6 | 23.5 | signal |
| 32 | Systemic Lupus Erythematosus | 30 | 22.5 | 23.3 | signal |
| 33 | Gait Inability | 28 | 22.4 | 23.2 | signal |
| 34 | Ear Pain | 16 | 21.8 | 22.3 | signal |
| 35 | Type 2 Diabetes Mellitus | 27 | 21.2 | 21.9 | signal |
| 36 | Stomatitis | 47 | 20.6 | 21.8 | signal |
| 37 | Psoriatic Arthropathy | 31 | 20.4 | 21.2 | signal |
| 38 | Respiratory Disorder | 23 | 20.3 | 20.9 | signal |
| 39 | Impaired Healing | 25 | 20.2 | 20.8 | signal |
| 40 | Osteoarthritis | 32 | 20.0 | 20.8 | signal |
| 41 | Prescribed Underdose | 15 | 19.9 | 20.3 | signal |
| 42 | Therapeutic Product Effect Decreased | 33 | 19.7 | 20.5 | signal |
| 43 | Sleep Disorder | 50 | 19.0 | 20.2 | signal |
| 44 | Inflammation | 36 | 18.6 | 19.4 | signal |
| 45 | Liver Injury | 16 | 17.5 | 17.9 | signal |
| 46 | Memory Impairment | 89 | 17.2 | 19.2 | signal |
| 47 | Sciatica | 10 | 16.7 | 16.9 | signal |
| 48 | Lower Limb Fracture | 12 | 16.7 | 16.9 | signal |
| 49 | Blister | 35 | 16.6 | 17.3 | signal |
| 50 | Blood Cholesterol Increased | 29 | 16.5 | 17.1 | signal |
| 51 | Liver Function Test Increased | 13 | 16.2 | 16.4 | signal |
| 52 | Hypoaesthesia | 90 | 15.9 | 17.8 | signal |
| 53 | Paraesthesia | 92 | 15.5 | 17.4 | signal |
| 54 | Pulmonary Fibrosis | 11 | 15.3 | 15.5 | signal |
| 55 | Arthropathy | 30 | 14.3 | 14.8 | signal |
| 56 | Maternal Exposure During Pregnancy | 47 | 14.1 | 15.0 | signal |
| 57 | Wheezing | 30 | 13.4 | 13.9 | signal |
| 58 | Neck Pain | 28 | 13.3 | 13.7 | signal |
| 59 | Application Site Pain | 11 | 13.3 | 13.4 | signal |
| 60 | Joint Stiffness | 13 | 13.1 | 13.3 | signal |
| 61 | Abdominal Pain Upper | 97 | 12.5 | 14.1 | signal |
| 62 | Treatment Failure | 38 | 12.3 | 12.8 | signal |
| 63 | Rheumatoid Arthritis | 50 | 11.7 | 12.5 | signal |
| 64 | Coeliac Disease | 4 | 10.8 | 10.9 | signal |
| 65 | Insurance Issue | 6 | 10.7 | 10.8 | signal |
| 66 | Injury | 28 | 10.5 | 10.9 | signal |
| 67 | Product Prescribing Issue | 8 | 10.4 | 10.5 | signal |
| 68 | Skin Irritation | 18 | 10.4 | 10.6 | signal |
| 69 | Foot Deformity | 4 | 9.6 | 9.6 | signal |
| 70 | Basal Cell Carcinoma | 5 | 8.5 | 8.5 | signal |
| 71 | Product Quality Issue | 42 | 8.3 | 8.7 | signal |
| 72 | Drug Effect Less Than Expected | 4 | 7.5 | 7.6 | signal |
| 73 | Skin Burning Sensation | 20 | 7.5 | 7.6 | signal |
| 74 | Product Packaging Quantity Issue | 3 | 7.3 | 7.3 | signal |
| 75 | Incorrect Product Administration Duration | 5 | 6.5 | 6.6 | signal |
| 76 | Exposure During Pregnancy | 15 | 6.4 | 6.5 | signal |
| 77 | Acne | 16 | 5.6 | 5.7 | signal |
| 78 | Dermatitis Atopic | 10 | 5.3 | 5.4 | signal |
| 79 | Application Site Erythema | 5 | 5.0 | 5.1 | signal |
| 80 | Complication Of Device Removal | 3 | 4.7 | 4.7 | signal |
| 81 | Abortion Spontaneous | 5 | 3.3 | 3.3 | signal |
| 82 | Device Dislocation | 4 | 2.4 | 2.5 | no signal |